Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Protein phosphatase 1 catalytic subunit (PP1c) is a major eukaryotic serine/threonine phosphatase responsible for dephosphorylating a significant portion of phosphoserine and phosphothreonine residues in mammalian cells. While the free catalytic subunit lacks inherent substrate specificity, it achieves high selectivity in vivo by associating with over 200 different regulatory or targeting subunits to form distinct holoenzymes. These complexes allow PP1 to regulate a vast array of cellular processes, including glycogen metabolism, muscle contraction, cell cycle progression, and neuronal signaling. Dysregulation of PP1 activity is implicated in numerous pathologies, such as heart failure, where altered dephosphorylation of calcium-handling proteins occurs, and neurodegenerative diseases like Alzheimer's, characterized by tau hyperphosphorylation. In oncology, PP1 is involved in regulating cell survival and division pathways. While many natural toxins like okadaic acid act as potent inhibitors of the PP1 catalytic site, therapeutic development focuses on targeting specific PP1-regulatory subunit interactions to achieve precision and avoid the systemic toxicity associated with broad phosphatase inhibition.
Inhibition of serine/threonine dephosphorylation by binding to the catalytic site or disrupting the formation of specific holoenzyme complexes.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein phosphatase 1 catalytic subunit (PP1c).